NeuroOne Medical Technologies Corporation — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 29 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$3M↓-11.7%$-1M↓-180.5%-59.0%
2025-09-30$3M↑+906.6%
2025-06-30$2M↑+105.4%$-2M↑+45.8%-111.2%
2025-03-31$1M↑+0.7%$-2M↑+20.5%-193.3%
2024-12-31$3M↑+234.9%$2M↑+153.4%52.3%
2024-09-30$272K↓-63.3%
2024-06-30$826K↑+31.1%$-3M↑+20.2%-338.3%
2024-03-31$1M↑+195.4%$-3M↑+19.0%-209.5%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$3M
↓-11.7% -$382K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 62 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-4.7pts
54.2%
Operating Margin↓-111.3pts
-59.0%
Net Margin↓-104.2pts
-49.7%

Go deeper